$6.69
-0.08-1.18%
At Close: -
$6.86
0.172.47%
After Hours: 6:36 PM EDT
15 minutes delayed
Inovio Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Inovio Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-1.19 | $-1.10 | -8.18 % |
Mar 2024 | 2024-05-13 | $-1.31 | $-1.00 | -31.0 % |
Dec 2023 | 2024-03-06 | $-1.10 | $-1.27 | 13.4 % |
Sep 2023 | 2023-11-09 | $-1.56 | $-1.56 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $100.76K | $120.00K | -16.0 % |
Dec 2023 | 2024-03-06 | $103.00K | $340.00K | -69.7 % |
Sep 2023 | 2023-11-09 | $388.45K | $120.00K | 223.7 % |
Jun 2023 | 2023-08-09 | $225.97K | $260.00K | -13.1 % |
Inovio Pharmaceuticals (INO) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-1.19, which missed the estimate of $-1.10.
The Actual Revenue was $100.8K, which missed the estimate of $120K.
Browse earnings estimates, EPS, and revenue on all stocks.